Your body isn't broken.
It's responding to the wrong signals.
by Retatrutide — the most advanced metabolic compound available
prepared through a pharmaceutical-grade compounding lab
not adapted from a template or forum stack
nutrition specialist and client lead
You're not failing.
Your biology is running a different programme.
The Real Problem
"Most clients who come to us have been doing everything right for a long time. They don't need more discipline. They need the biology working with them, not against them."
Most people who come to Eternal Wellness Center have already done the work. They've tracked calories, trained consistently, tried intermittent fasting, done everything the standard advice says. And they've hit a ceiling that willpower can't move.
That ceiling isn't a character flaw. It's biology. Appetite hormones. Growth hormone decline. Insulin sensitivity. Metabolic adaptation. These are upstream signals — and until you address them at the signal level, you're fighting your own physiology with a blunt instrument.
- Diet and training aren't producing results proportional to the effort being invested
- Fat — particularly visceral or abdominal fat — is resistant regardless of caloric approach
- Appetite feels genuinely difficult to regulate, not a matter of willpower
- Weight loss is occurring but muscle mass is being compromised alongside it
- Progress plateaued months ago and hasn't moved despite protocol adjustments
- Metabolic rate feels slow — energy is low even on adequate calories
- Previous weight loss medications produced side effects or poor results
Metabolic signalling,
rebuilt from the ground up.
The Fat Loss & Body Recomposition Protocol is not a diet plan. It is not a generic GLP-1 prescription. It is a specialist-designed peptide protocol that addresses the biological signals governing appetite, fat metabolism, growth hormone output and body composition — built around your specific bloodwork, health history and goals.
Peter designs every protocol individually. Retatrutide — a triple-receptor agonist targeting GLP-1, GIP and glucagon simultaneously — is frequently the lead compound for clients with significant fat loss goals. NAD+, CJC-1295 and Ipamorelin are calibrated alongside or independently depending on your picture.
Trevor builds the nutritional and lifestyle architecture to ensure your body has the raw materials to execute the signal correctly — particularly protein targets and micronutrient support for lean tissue preservation throughout a fat loss phase.
This is the distinction between a prescription and a protocol. A prescription gives you a compound. A protocol gives you a compound, a design rationale, a nutritional framework, monitoring checkpoints and a specialist team tracking the outcome.
GLP-1 receptor agonists — particularly Retatrutide — reduce appetite at the hormonal level, not through stimulants or willpower augmentation. Hunger becomes physiologically manageable rather than a constant resistance exercise.
Glucagon receptor activation increases energy expenditure and drives preferential fat oxidation — meaning more of your caloric deficit comes from fat stores rather than lean tissue. This is the critical recomposition signal.
Growth hormone secretagogues support anabolic signalling throughout the fat loss phase. Combined with Trevor's protein and micronutrient framework, this keeps the scales moving the right direction — fat down, lean mass protected.
Metabolic dysfunction and fat accumulation are frequently downstream of poor insulin sensitivity. This protocol addresses that upstream — improving how your body partitions nutrients rather than simply restricting them.
This isn't suppression.
It's correction.
Conventional fat loss approaches restrict input and hope the body responds. Peptide therapy changes the upstream signals governing how the body manages energy — a fundamentally different mechanism.
Glucagon-like peptide-1 receptors govern satiety signalling, gastric emptying rate and insulin secretion. Activating these receptors reduces appetite at a physiological level — not through stimulation, but through genuine satiety signal restoration. The result is a caloric environment that the body accepts rather than fights.
Gastric inhibitory polypeptide receptor activation enhances insulin secretion in a glucose-dependent manner and contributes to improved lipid metabolism. In combination with GLP-1 activation, GIP creates a synergistic metabolic environment that single-agonist compounds cannot replicate — which is part of what makes Retatrutide's data so compelling.
Glucagon receptor activation directly increases resting energy expenditure and drives hepatic fat oxidation — meaning your metabolic rate increases and fat stores are preferentially mobilised as fuel. This is the third mechanism unique to Retatrutide and the one that drives the outsized body composition outcomes seen in clinical research.
Growth hormone secretagogues — CJC-1295 and Ipamorelin — restore the natural GH pulse frequency that declines significantly from the mid-30s onward. This supports lipolysis, lean tissue preservation and metabolic efficiency. Combined with the GLP-1/GIP/glucagon axis, the protocol creates both a fat loss signal and a body composition preservation signal simultaneously.
Trevor designs the nutritional environment to support the peptide signal. Protein targets are set to protect lean tissue throughout the fat loss phase. Micronutrient priorities are identified from bloodwork. The distinction between a protocol and a prescription is precisely this — the biological signal needs the raw materials to execute. Trevor ensures they're in place.
Peter reviews your progress at defined checkpoints throughout the protocol. Dose, timing and compound selection can be adjusted as your metabolic response becomes clear. The protocol is designed around a starting picture and refined against the actual outcome — a living document, not a fixed script handed out on day one.
Pharmaceutical-grade tools. Protocol-grade precision.
Peter selects compounds based on your individual metabolic picture. These are the tools most commonly used in a fat loss and body recomposition context — your protocol may include one, several, or a specifically designed combination.
A triple-receptor agonist targeting GLP-1, GIP and glucagon simultaneously — producing the most comprehensive metabolic signalling profile currently available in this category. Clinical research has demonstrated greater weight reduction outcomes than any single-agonist compound. For clients with meaningful fat loss goals and no contraindications, Retatrutide is where Peter starts. It addresses appetite regulation, metabolic rate and fat mobilisation through three independent mechanisms at once — a level of precision that single-agonist approaches simply cannot replicate.
The combination that separates a fat loss protocol from a simple weight loss prescription. CJC-1295 No DAC and Ipamorelin work together to restore the natural growth hormone pulse rhythm — the version that mimics your own physiology rather than flooding the system. The result is enhanced fat metabolism, improved body composition partitioning and — critically — preservation of lean muscle tissue throughout the fat loss phase. Without this, significant caloric deficit and appetite suppression frequently comes at the cost of muscle mass. Peter includes this stack specifically to prevent that trade-off.
Nicotinamide Adenine Dinucleotide — the coenzyme your cells require to produce energy efficiently. NAD+ levels decline significantly with age, and low NAD+ is directly associated with reduced metabolic rate, mitochondrial inefficiency, fatigue and impaired cellular repair. In a fat loss context, NAD+ replenishment supports the energy production systems that active fat metabolism depends on — meaning the rest of the protocol executes against a cellular environment that is actually equipped to respond. Most clients also report noticeably improved energy and mental clarity within the first few weeks of NAD+ inclusion.
When the signals are right,
the body does what it was always capable of.
Most clients describe it the same way before they come to us. Not hunger exactly — noise. A near-constant mental occupation with food that runs in the background all day. What to eat, whether they've had too much, what they'll allow later. It is exhausting in a way that's hard to explain to someone who hasn't lived it.
That noise is not a discipline problem. It's a physiological signal — and it's one of the first things that changes on a correctly designed protocol. Within the first weeks, clients consistently report the same shift: the noise quiets. Portions feel satisfying. Food stops being what the brain returns to between every other thought. For many clients, it's the most significant quality of life change the entire protocol produces — and it happens before the scale has moved meaningfully.
Fat that has been diet-resistant — particularly abdominal and visceral accumulation — responds to compounds that work at the metabolic signalling level. Clients typically notice changes in body measurements and clothing fit before the scale meaningfully reflects what is happening in body composition terms.
Fat loss without muscle preservation is the wrong outcome. The GH secretagogue component of the protocol — and Trevor's nutritional framework keeps the anabolic environment intact throughout a caloric deficit. You lose fat. You don't lose what you've built.
As metabolic signalling normalises, energy levels typically improve even in the presence of a caloric deficit. The metabolic sluggishness that characterises diet-induced adaptation — where restriction leads to fatigue and reduced NEAT — is less pronounced when the signalling environment supports efficient fat oxidation.
One of the less discussed but most clinically meaningful outcomes of a well-designed metabolic protocol. Improved insulin sensitivity changes how your body partitions nutrients long-term — not just during the active protocol phase. Clients who address this upstream signal often find that maintaining results becomes structurally easier than it has ever been.
Six client profiles.
One common denominator.
The biology stopped cooperating. The protocol is designed to change that. These are the profiles we see most consistently — though your specific picture will always be assessed individually by Peter before any protocol begins.
You train regularly, eat well and are not dramatically overweight — but a layer of body fat, particularly around the abdomen, has not moved regardless of caloric or training adjustments. This is one of the clearest presentations of a metabolic signalling issue rather than a discipline issue. Peter's protocol is frequently the first thing that actually moves it.
What worked at 32 stopped working at 42. Caloric approaches that previously produced results now produce nothing, or produce results that reverse immediately. Growth hormone decline, changing insulin dynamics and shifting body composition partitioning are all real biological events — and they respond to protocol-level intervention, not just harder dieting.
You have more than a cosmetic goal — you're carrying excess weight that is affecting your energy, your joints, your confidence and your health. Previous approaches — diets, medications, programmes — have produced incomplete or temporary results. A Retatrutide-led protocol addresses the appetite and metabolic signals at the level where meaningful, sustained change becomes structurally possible.
Your goal isn't just fat loss — it's body recomposition. You want to lose fat and maintain or build lean tissue simultaneously, which conventional caloric restriction makes very difficult without the right anabolic signal in place. The combination of a GLP-1 compound and GH secretagogues creates exactly this dual environment — fat loss signal and muscle preservation signal operating together.
You've used semaglutide before — perhaps from a GP or another clinic — and it produced partial results or plateaued. You're aware of Retatrutide and want to understand whether a triple-agonist protocol is appropriate for your profile. Peter assesses this specifically. If upgrading is the right move, the protocol is designed with that transition in mind.
You're already running a broader health optimisation stack and want to add a properly designed fat loss and recomposition component. You want pharmaceutical-grade compounds, a peptide and hormone specialist who designs the interaction picture carefully, and a nutritional specialist who accounts for the broader protocol context. This is exactly the level of clinical design Peter and Trevor provide.
This protocol requires a full health screening with Peter before any compound is prescribed. It is not appropriate for clients who are pregnant or breastfeeding, those with a personal or family history of medullary thyroid carcinoma or MEN2, clients with active pancreatitis, or anyone with a contraindicated medication interaction that Peter identifies at screening. If you are unsure whether you qualify, complete the consultation form — Peter will review your picture and give you an honest answer. We do not design protocols for people who shouldn't be on them.
Anyone can write a GLP-1 script.
Almost nobody does what we do around it.
The compound is one part. The protocol design, nutritional architecture, monitoring framework and ongoing specialist access are what determine whether the outcome is a temporary result or a permanent shift.
The GLP-1 and metabolic peptide market has a serious quality and sourcing problem. Degraded compounds, incorrect concentrations, cold-chain failures and unmonitored protocols are standard practice in the grey market. A degraded or incorrectly dosed compound injected into your system isn't just ineffective — it's an unknown variable.
Fat loss takes time.
Here's what the right timeline actually looks like.
This protocol is not a quick fix. It is a structural reset of the signals governing your metabolism. The timeline below reflects what most clients experience when the protocol is designed correctly and the nutritional environment supports it.
Peter reviews your full health picture — bloodwork if available, medications, body composition goals, health history and any previous experience with GLP-1 or metabolic compounds. Compound selection, dose titration schedule and cycle length are determined at this stage. Trevor maps your nutritional framework. The consultation form is where this starts — it takes a few minutes and it's what makes everything else possible.
Dose titration begins conservatively and increases according to your tolerance and response. Appetite changes are typically the first thing clients notice — portions feel satisfying earlier, food fixation reduces, and the psychological weight of caloric management begins to lift. Some clients experience mild nausea during the initial titration phase; Peter designs the titration schedule to minimise this. Weight change at this stage varies — the metabolic environment is shifting before the scale reflects it.
This is where body composition changes become visible and measurable. Clients typically report consistent weekly progress — both on the scale and in measurements — without the energy crashes or hunger spikes that characterise conventional caloric restriction. The GH secretagogue component (where included) supports lean tissue preservation throughout this phase. Peter reviews your progress and adjusts dose or protocol parameters where needed.
Peter reviews your outcomes at the end of the first cycle. For clients who have reached their goal, a structured dose reduction and maintenance protocol prevents the rebound that typically follows abrupt cessation. For clients with further to go, a second cycle is assessed. The goal is not indefinite protocol dependency — it is a metabolic reset that is sustainable beyond the active protocol phase, supported by Trevor's long-term nutritional architecture.
Willpower is finite. Biology is persistent. The protocol changes the biology — so the willpower finally gets to rest.
What changes when the biology
finally starts working with you.
Real outcomes from real protocols. Names withheld for privacy. Results are individual and depend on health history, starting point, protocol design and commitment to the full programme.
"I'd tried semaglutide twice before through different sources. Both times I lost some weight and it came straight back when I stopped. Peter switched me to Retatrutide and built a proper protocol around it — not just the compound, but the nutrition framework and the monitoring. Fourteen weeks later I'm down 18kg and for the first time in years my appetite actually feels like mine. I'm not fighting it every day."
"My goal wasn't just fat loss — I wanted to actually recomp. I'd been training for years and couldn't shift the abdominal fat without losing muscle. Peter designed a protocol with semaglutide and CJC-1295/Ipamorelin together, Trevor sorted the protein and micronutrient targets, and over sixteen weeks I dropped 11kg of fat and actually added lean mass at the same time. My body now looks like the effort I've been putting in for years."
"At 44, everything that used to work stopped working. Same calories, same training — completely different result than my 30s. Peter explained the biology clearly — it wasn't effort, it was the signalling environment that had changed. The protocol addressed that directly. By week six I was losing consistently for the first time in three years. By week twelve my body felt genuinely different — energy, composition, the way I move. I wish I'd done this two years earlier."
Clinical design means
safety is non-negotiable.
Every protocol begins with a full health screening. No compound is prescribed without Peter reviewing your complete picture first. These are the non-negotiable safety principles that govern every fat loss protocol we design.
No protocol begins without Peter reviewing your complete health picture — bloodwork, medications, medical history and any contraindications. This is not a formality. It directly determines whether and how we proceed.
Every compound is sourced from a pharmaceutical-grade compounding lab. Concentration accuracy, cold-chain integrity and sterility are maintained to pharmaceutical standards. We do not use research-grade or grey-market sources under any circumstances.
GLP-1 and metabolic compounds require a managed titration schedule — dose increases are staged based on tolerance and response. Peter manages this process with defined check-in points, not a fixed script. Side effect minimisation is built into how the protocol is designed from day one.
The compounds used in this protocol do not suppress your endocrine axis the way anabolic steroids or synthetic hormones do. GLP-1 agonists and GH secretagogues work with your existing hormonal architecture — they do not replace or suppress it. No post-cycle therapy is required.
The information on this page is for educational purposes and does not constitute medical advice. All protocols at Eternal Wellness Center are designed by a peptide and hormone specialist following a full individual health screening. Results vary by individual. Peptide therapy is not appropriate for all health profiles — contraindications are assessed at the consultation stage. In the event of any adverse reaction, cease use immediately and seek medical attention.
Straight answers.
No deflection.
The questions we hear most often — answered honestly. If yours isn't here, the consultation form gets it to Peter directly.
Protocol design is individual — Peter selects compounds based on your metabolic picture, bloodwork, health history and body composition goals. Compounds commonly explored in this category include Retatrutide, Semaglutide, CJC-1295 with Ipamorelin, and Tesamorelin for visceral fat. Your protocol will be designed specifically for you — not adapted from a template.
Retatrutide is a triple receptor agonist targeting GLP-1, GIP and glucagon receptors simultaneously — making it the most comprehensive metabolic signalling compound currently available in this category. Semaglutide targets GLP-1 only. In clinical research, Retatrutide has demonstrated significantly greater weight reduction outcomes than single-agonist compounds. Peter assesses which compound — or which combination — is appropriate for your specific metabolic profile.
Muscle preservation is a primary design consideration in how Peter structures these protocols. GH secretagogues like CJC-1295 and Ipamorelin support anabolic signalling during a caloric deficit — and Trevor's nutritional framework ensures protein targets and key micronutrients are in place to support lean tissue retention throughout. Fat loss without muscle preservation is not a goal we design toward.
Most clients notice meaningful changes in appetite regulation and energy within the first 2 to 4 weeks. Visible body composition changes typically require 8 to 16 weeks depending on starting point, protocol design and nutritional compliance. Peter sets honest expectations at the outset — timelines are protocol-specific and individual.
Because most approaches address behaviour without addressing biology. If your metabolic signalling, appetite hormones, growth hormone pulse frequency or insulin sensitivity are working against you, no amount of dietary willpower can fully override that. A well-designed peptide protocol addresses those upstream signals — which is why clients who have tried everything else often see different results here.
Yes. Many of our clients are international. The consultation, health screening review and protocol design all happen remotely. I coordinate the entire process from first contact through to aftercare, regardless of your location. Start with the free consultation form and we'll map out what the logistics look like for you specifically. We have a delivery guarantee warranty on each purchase, we've never failed at getting someone's products to them and we are not about to start.
Want to know what clients typically notice?
Read the realistic timelines, tracking points, and expectation-setting we use before anyone begins a protocol.
Read Results & What to Expect →
The biology can change.
This is where that starts.
Fill in the free consultation form. Peter reviews your picture. We build the protocol around you — not around a template, not around a generic script. Specialist review from a peptide and hormone specialist, with a team that keeps the whole thing together throughout.
Free consultation. No obligation. Peter reviews every submission personally before responding.
Remote clients welcome — we'll map out your logistics from here.